Edition:
United Kingdom

CTI Biopharma Corp (CTIC.OQ)

CTIC.OQ on NASDAQ Stock Exchange Capital Market

3.90USD
4:18pm BST
Change (% chg)

$0.03 (+0.78%)
Prev Close
$3.87
Open
$3.89
Day's High
$3.91
Day's Low
$3.88
Volume
6,604
Avg. Vol
84,145
52-wk High
$4.51
52-wk Low
$2.46

Select another date:

Fri, Mar 9 2018

BRIEF-Children's Hospital Of Philadelphia Foundation To Engage In Dialogue With Spark Therapeutics To Be Allowed To Designate At Least 1 Board Member

* CHILDREN'S HOSPITAL OF PHILADELPHIA FOUNDATION - TO ENGAGE IN DIALOGUE WITH SPARK THERAPEUTICS TO BE ALLOWED TO DESIGNATE AT LEAST 1 BOARD MEMBER

BRIEF-CTI Biopharma Q4 Loss Per Share $0.33

* CTI BIOPHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Tempest Therapeutics Inc Says It Has Raised $25.2 Million In Equity Financing

* TEMPEST THERAPEUTICS, INC FILES TO SAY IT HAS RAISED $25.2 MILLION IN EQUITY FINANCING - SEC FILING​

BRIEF-Growth Equity Opportunities Fund Reports 6.0 Pct Stake In CTI Biopharma

* GROWTH EQUITY OPPORTUNITIES FUND V LLC REPORTS 6.0 PERCENT STAKE IN CTI BIOPHARMA CORP AS OF FEB 8 - SEC FILING

BRIEF-CTI BioPharma Prices Underwritten Public Offering Of $60 Million Of Common Stock

* CTI BIOPHARMA PRICES UNDERWRITTEN PUBLIC OFFERING OF $60 MILLION OF COMMON STOCK

BRIEF-CTI Biopharma Announces Launch Of Follow-On Offering

* CTI BIOPHARMA CORP - INTENDS TO USE NET PROCEEDS OF OFFERING TO COMPLETE PAC203 CLINICAL TRIAL, COMPLETE REVIEW OF PACRITINIB MAA BY EMA, AMONG OTHERS Source text for Eikon:

BRIEF-CTI Biopharma Provides Corporate And European Regulatory Update

* CTI BIOPHARMA PROVIDES CORPORATE AND EUROPEAN REGULATORY UPDATE

BRIEF-CTI BioPharma to receive $10 mln milestone payment for Trisenox

* CTI BIOPHARMA TO RECEIVE $10 MILLION MILESTONE PAYMENT FOR TRISENOX®

BRIEF-Spotlight Therapeutics Inc Says It Has Raised $7.3 Million In Equity Financing

* SPOTLIGHT THERAPEUTICS INC FILES TO SAY IT HAS RAISED $7.3 MILLION IN EQUITY FINANCING - SEC FILING​

BRIEF-CTI Biopharma Corp Says Co Entered Into A Loan And Security Agreement​

* CTI BIOPHARMA CORP - ‍ON NOVEMBER 28, 2017, CTI BIOPHARMA CORP ENTERED INTO A LOAN AND SECURITY AGREEMENT​

Select another date: